Vivos Therapeutics (VVOS) Non-cash Items (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Non-cash Items data on file, last reported at $174000.0 in Q1 2026.

• Quarterly Non-cash Items changed N/A year-over-year to $174000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174000.0 (changed N/A YoY) and the FY2025 annual result came in at $177000.0, changed N/A from the prior year.
• Non-cash Items slipped to $174000.0 in Q1 2026 per VVOS's latest filing, from $177000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $2.1 million in Q2 2022 and bottomed at $89000.0 in Q4 2023.
• The 5-year median for Non-cash Items is $147500.0 (2024), against an average of $674500.0.
• Peak annual rise in Non-cash Items reached 84.43% in 2022, while the deepest fall reached 95.26% in 2022.
• Tracing VVOS's Non-cash Items over 5 years: stood at $90000.0 in 2022, then slipped by 1.11% to $89000.0 in 2023, then soared by 35.96% to $121000.0 in 2024, then surged by 46.28% to $177000.0 in 2025, then fell by 1.69% to $174000.0 in 2026.
• Per Business Quant, the three latest VVOS Non-cash Items figures stand at $174000.0 (Q1 2026), $177000.0 (Q4 2025), and $121000.0 (Q3 2024).

Peer Comparison